Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Finished Goods (2022 - 2026)

HeartSciences' Finished Goods history spans 5 years, with the latest figure at $22221.0 for Q1 2026.

  • For Q1 2026, Finished Goods fell 1.59% year-over-year to $22221.0; the TTM value through Jan 2026 reached $22221.0, down 1.59%, while the annual FY2025 figure was $44069.0, 95.16% up from the prior year.
  • Finished Goods reached $22221.0 in Q1 2026 per HSCS's latest filing, roughly flat from $22221.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $44069.0 in Q2 2025 to a low of $22221.0 in Q4 2025.
  • Average Finished Goods over 5 years is $28262.7, with a median of $28662.0 recorded in 2022.
  • Peak YoY movement for Finished Goods: dropped 21.22% in 2024, then skyrocketed 95.16% in 2025.
  • A 5-year view of Finished Goods shows it stood at $28663.0 in 2022, then decreased by 0.0% to $28662.0 in 2023, then decreased by 21.22% to $22581.0 in 2024, then dropped by 1.59% to $22221.0 in 2025, then changed by 0.0% to $22221.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Finished Goods are $22221.0 (Q1 2026), $22221.0 (Q4 2025), and $44069.0 (Q3 2025).